title: Atomoxetine for the treatment of pediatric nocturnal enuresis.
abstract: Current treatments for pediatric nocturnal enuresis rely upon the use of behavioral interventions, such as enuresis alarms, and pharmacological interventions, such as antidiuretic hormone analogs, tricyclic antidepressants, and anticholinergics. However, a considerable number of patients do not respond fully to any of these interventions, in spite of optimal behavioral management and medication dosing. This report describes 4 children with attention deficit hyperactivity disorder (ADHD) comorbid with nocturnal enuresis. Each child was treated with atomoxetine for ADHD and experienced serendipitous resolution of enuresis.
authors.affiliation: Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. shatkinjp@upmc.edu
authors.forename: Jess P
authors.initials: JP
authors.lastname: Shatkin
mesh_terms: D000293:Adolescent; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000523:psychology; D002648:Child; D004775:Enuresis / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008297:Male; D011437:Propylamines / Q000627:therapeutic use*
chemical_list: D011437:Propylamines; D000069445:Atomoxetine Hydrochloride